Scribd Logo
Upload

Welcome to Scribd!

  • R1MC Pedia RHD Drug Study Ni Holy

    Uploaded by

    Holyver Tabarnilla
    6 views2 pages
    This document provides information about the drug cilostazol. It lists the drug's classification as a platelet aggregation inhibitor, its mechanism of action by inhibiting phosphodiesterase activity and suppressing an increase in platelets. It is indicated for the alleviation of symptoms of intermittent claudication pain in the legs that occurs with walking. The nursing responsibilities include implementing therapeutic and ambulation activities to augment the drug's effect and promote increased walking distance.

    Original Description:

    Original Title

    R1MC PEDIA RHD DRUG STUDY NI HOLY

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document provides information about the drug cilostazol. It lists the drug's classification as a platelet aggregation inhibitor, its mechanism of action by inhibiting phosphodiesterase activity and suppressing an increase in platelets. It is indicated for the alleviation of symptoms of intermittent claudication pain in the legs that occurs with walking. The nursing responsibilities include implementing therapeutic and ambulation activities to augment the drug's effect and promote increased walking distance.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    6 views2 pages

    R1MC Pedia RHD Drug Study Ni Holy

    Uploaded by

    Holyver Tabarnilla
    This document provides information about the drug cilostazol. It lists the drug's classification as a platelet aggregation inhibitor, its mechanism of action by inhibiting phosphodiesterase activity and suppressing an increase in platelets. It is indicated for the alleviation of symptoms of intermittent claudication pain in the legs that occurs with walking. The nursing responsibilities include implementing therapeutic and ambulation activities to augment the drug's effect and promote increased walking distance.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 2

    NORTHERN LUZON ADVENTIST COLLEGE

    Artacho, Sison, Pangasinan


    A SEVENTH -DAY ADVENTIST INSTITUTION
    Accredited by ACSCU -AAI & IBE -AA
    SCHOOL OF NURSING
    Tel. No. 075 -632 -2290 http://www.nlac.edu.p h e -mail address: Info@nlac.edu.ph ; dean.nursing.nlac@gmail.com

    DRUG STUDY
    Name of Student: Holyver Tabarnilla Subject/Area of Exposure: R1MC/PEDIA WARD

    Name of CI: Ervin Gelido,Rn


    Name of Drug Classification Mechanism of Indication Contraindication Adverse Effect Nursing
    Action Responsibilities
    Generic Name PLATELET- INHIBITING FOR THE HYPERSENSITIVITY MAY CAUSE IMPLEMENT
    CILOSTASOL AGGREGATION PHOSPHODIESTERASE ALLEVATION OF HEMOSTATIC THERAPEUTIC
    DISORDERS HEART
    INHIBITOR ACTIVITY AND SYMPTOMS OF AND
    SUPPRESSING Camp INTERMITTENT OR ACTIVE PROBLEMS
    PATHOLOGIC AMBULATION
    Brand Name: INCREASE IN CLAUDICATION
    BLEEDING ACTIVITIES TO
    PLETAL PLATELETS -PAIN IN THE LEGS
    AUGMENT THE
    AND BLOOD VESSELS THAT OCCURS
    LEADING TO WITH WALKING
    EFFECT OF
    Dosage: DRUGS THERAPY
    INHIBITION AND DISSAPPERS
    1 TAB 50MG AND PROMOTE
    OF PLATELETS WITH REST
    AGGREGATION AND INCREASED
    VASODILATION WALKING
    Route:
    DISTANCE
    ORAL

    Frequency:
    BID

    You might also like